Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
Denver Women's Recovery, located in Denver, CO, is a dedicated rehabilitation facility designed specifically for adult women who are in need of treatment for substance use and related significant mental health challenges. The center provides various treatment options, such as intensive outpatient care and standard outpatient sessions, utilizing proven methods like cognitive behavioral therapy and contingency management. Tailored to meet the needs of adult women, seniors, and young adults affected by intimate partner violence, Denver Women's Recovery emphasizes personalized programs that ensure high-quality care and focused assistance. Additionally, active duty military members looking for recovery help are encouraged to seek services at this center.
Desert Comprehensive Treatment Center, situated in Palm Springs, CA, provides an array of outpatient services including detoxification, treatment for substance use, and medication-assisted therapies such as methadone, buprenorphine, or naltrexone. The center focuses on techniques like motivational interviewing, relapse prevention strategies, and counseling for substance use disorders. It particularly emphasizes support for pregnant and postpartum women, while serving adults and young adults of all genders. With a commitment to delivering high-quality care, Desert Comprehensive Treatment Center creates personalized treatment plans aimed at helping individuals conquer addiction. Whether for yourself or someone you care about, this facility presents a variety of compassionate addiction treatment options designed to cater to different needs.
Desert Hope, situated in Las Vegas, NV, is a premier treatment center dedicated to addressing substance use disorders and concurrent mental health challenges for individuals of all ages. The facility offers a range of programs, including intensive outpatient, outpatient services, and day treatment, all customized to meet the unique requirements of each client. Desert Hope employs specialized approaches such as anger management, cognitive behavioral therapy, and brief intervention strategies to provide thorough care for adults, particularly those with co-occurring conditions. Catering to adults and young adults across the gender spectrum, this center prioritizes delivering exceptional, individualized support to guide them toward lasting recovery.
Desert Hope Treatment Center, situated in Las Vegas, NV, delivers complete care for those battling addiction and co-occurring mental health challenges. This center features inpatient hospital detox and treatment plans designed for adults and young adults. Desert Hope Treatment Center employs proven therapeutic methods like cognitive behavioral therapy, brief interventions, and anger management, offering distinct programs for adult men, adult women, and individuals with dual diagnoses. The facility is committed to delivering exceptional treatment, prioritizing the distinct requirements of each person to foster enduring sobriety.
Denver Recovery Group, located in Denver, CO, provides outpatient treatment for substance use disorders aimed at both adults and seniors. The center specializes in caring for pregnant and postpartum women, accommodating clients of all genders. Their treatment methods encompass anger management, cognitive behavioral therapy, as well as contingency management and motivational incentives. Clients have access to personalized outpatient options like methadone, buprenorphine, or naltrexone. Denver Recovery Group is committed to delivering high-quality care and customized programs to address the distinct needs of each individual pursuing recovery in a nurturing setting.
The VA Medical Center in Dallas, Texas, delivers extensive substance abuse recovery programs for adults and adolescents. This institution features hospital-based inpatient detox and care for various addictions, addressing co-occurring mental health issues as well. They offer distinct tracks for adult males, adult females, and survivors of domestic abuse, guaranteeing personalized support. Employing strategies such as 12-step peer support and emotional regulation techniques, the center emphasizes customized recovery journeys. Committed to high standards of treatment and a nurturing atmosphere, this center is devoted to guiding individuals toward lasting sobriety.
Situated in Beckley, WV, the Department of Veterans Affairs Medical Center provides an extensive array of outpatient services aimed at treating substance use disorders alongside concurrent mental health challenges for both adults and children. The center is particularly dedicated to veterans, offering services that include detoxification, as well as outpatient treatments utilizing methadone, buprenorphine, or naltrexone. Additionally, the facility employs diverse therapeutic methods such as anger management, brief intervention, and cognitive behavioral therapy. Committed to delivering high-quality care, this center supports adult and young adult patients of all genders in their pursuit of personalized rehabilitation programs designed to meet their specific needs.
Situated in Colorado Springs, Colorado, Denver Recovery Group provides extensive outpatient services for drug and alcohol dependency, serving both adults and adolescents. The center's core offerings include outpatient medication-assisted treatment using methadone, buprenorphine, or naltrexone. Their therapeutic modalities incorporate techniques like anger management, cognitive behavioral therapy, and motivational enhancement strategies. Denver Recovery Group is particularly adept at delivering specialized care for pregnant and postpartum women, alongside comprehensive support for all male and female patients. The facility is recognized for its dedication to high-standard care and personalized recovery journeys, positioning it as a premier option for individuals pursuing lasting sobriety through supportive and evidence-based methods.
Denver Recovery Group in Denver, CO, provides extensive addiction recovery services. Their offerings include standard outpatient care, medication-assisted treatment with methadone, buprenorphine, or naltrexone, and ongoing outpatient programs. The facility excels in delivering specialized therapies such as anger management, cognitive behavioral therapy, and contingency management, also known as motivational incentives. A distinctive feature is their dedicated program for expectant and new mothers. Catering to adult men and women, as well as young adults, Denver Recovery Group emphasizes personalized, evidence-based recovery plans. They are a reliable resource for individuals seeking expertly guided and effective addiction treatment in a nurturing setting.
Situated in Montrose, Colorado, Denver Recovery Group provides a wide array of outpatient services for both adult men and women, as well as young adults, who are in need of detoxification and substance use treatment. The center features tailored programs specifically for pregnant and postpartum women. Their therapeutic methods incorporate anger management strategies, cognitive behavioral therapy, and motivational incentives through contingency management. Offering various outpatient treatment options, including methadone, buprenorphine, or naltrexone, the facility guarantees personalized care to cater to a range of needs. Denver Recovery Group is committed to offering high-quality care with an emphasis on holistic recovery for individuals facing addiction challenges.
Desert Bloom Recovery LLC, located in Victorville, CA, specializes in the treatment of substance use disorders through multiple modalities, including intensive outpatient programs, standard outpatient services, and day treatment options. The center employs evidence-based methodologies such as 12-step programs, anger management techniques, and brief intervention strategies. It also features distinct programs designed for active duty military members and those impacted by partner violence or trauma. Catering to adults and young adults of diverse backgrounds, this facility prioritizes personalized care and support. Desert Bloom Recovery LLC is committed to providing exceptional and thorough rehabilitation services to assist individuals in attaining long-term recovery from addiction.
Outpatient substance use treatment with buprenorphine and naltrexone is available at Denver Indian Health and Family Servs in Denver, Colorado, for children, adolescents, adults, and seniors, with a program for clients with co-occurring mental disorders. IHS/Tribal/Urban funds, Medicare, Medicaid, and federal treatment funding are accepted.
Hospital inpatient detoxification and inpatient treatment, plus day treatment, intensive outpatient, and outpatient buprenorphine or naltrexone services, are provided at Denver Springs in Englewood, Colorado, for children, adolescents, adults, and seniors. Programs serve young adults, veterans, and clients with co-occurring mental disorders. Medicare, Medicaid, and TRICARE are accepted, with sign language services.
The Department of Veterans Affairs clinic in Lubbock, Texas offers outpatient detoxification, intensive outpatient treatment, and medication-assisted treatment with buprenorphine and naltrexone. Programs serve veterans, military families, pregnant and postpartum women, and clients with co-occurring disorders. No payment is accepted at this federally funded facility.
Outpatient detoxification, intensive outpatient treatment, and buprenorphine and naltrexone care for veterans in Honolulu, Hawaii, through the Department of Veterans Affairs STAR program. Services address co-occurring serious mental illness and trauma, with Medicare, TRICARE, and private insurance accepted.
Situated in Portsmouth, VA, the Dept of Behavioral Healthcare Services provides targeted treatment for substance use issues, including dual diagnosis for adults and emotional challenges in children. The center features outpatient services along with methadone and buprenorphine therapies, offering anger management, cognitive behavioral therapy, and short-term interventions. Customized programs are designed for adolescents, adult males, and females, addressing the needs of adults, young adults, and children/adolescents. Specialized care for males and females ensures individualized treatment plans. Experience exceptional quality of care and research-backed methods at this center, where individuals can access extensive support throughout their recovery journey.
Situated in Littleton, Colorado, Denver Recovery Group provides extensive outpatient treatment options for adults and young adults facing substance use issues. The center features targeted programs specifically designed for pregnant and postpartum women, addressing their distinct challenges. Employing evidence-based techniques like cognitive behavioral therapy and anger management, the facility also offers outpatient treatments involving methadone/buprenorphine or naltrexone. Committed to personalized care, Denver Recovery Group aims to support clients in attaining enduring sobriety. Both men and women can take advantage of the high-quality treatment programs tailored to enhance recovery and overall wellness.
Denver Recovery Group, located in Boulder, CO, specializes in extensive substance abuse rehabilitation for both adults and young adults. The facility offers a range of outpatient options, including methadone or buprenorphine management, naltrexone therapy, and tailored services for pregnant or postpartum women. Emphasizing evidence-based practices such as cognitive behavioral therapy, anger management, and motivational incentives, the center customizes treatment to meet the unique needs of each client. Both men and women receive exceptional support in a nurturing atmosphere designed to foster sustained recovery. For those in search of effective, individualized addiction treatment, Denver Recovery Group is ready to assist.
The Department of Human Services located in Sparta, WI, provides targeted outpatient care for adults facing substance use challenges and those with significant mental health issues, as well as for children experiencing serious emotional difficulties. This center emphasizes personalized treatment plans, utilizing proven methods such as cognitive behavioral therapy, motivational interviewing, and counseling specific to substance use disorders. It serves both male and female adults, including young adults, ensuring that each individual's unique needs are met. The Department of Human Services offers a variety of outpatient options, including treatments with methadone, buprenorphine, or naltrexone, affirming its commitment to delivering top-notch care to assist individuals in their recovery process.
Situated in Denver, Colorado, the Denver Recovery Group provides a diverse selection of outpatient services for addiction treatment. This center focuses on detoxification and substance use therapy for both adults and young adults. It offers outpatient options that include methadone/buprenorphine or naltrexone treatment, alongside standard outpatient programs and specialized services for pregnant or postpartum women. Emphasizing anger management, cognitive behavioral therapy, and motivational incentives, the Denver Recovery Group guarantees personalized attention for all clients. Enjoy compassionate care in a supportive atmosphere that fosters long-term recovery.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.